Literature DB >> 21039739

Potential value of serum total IgE for differentiation between autoimmune pancreatitis and pancreatic cancer.

A W van Toorenenbergen1, M J van Heerde, H R van Buuren.   

Abstract

Autoimmune pancreatitis (AIP) is associated with a marked elevation of serum total IgG₄ . Although there is evidence of autoimmunity in AIP, there are also signs of an allergic nature of its pathogenesis. Therefore, we determined both IgE and IgG₄ in 13 patients with AIP, in 12 patients with pancreatic carcinoma and in 14 patients with atopic allergy and investigated the relationship between IgE and IgG₄ . Total IgG₄ was determined by automated nephelometry and total IgE by automated enzyme fluoroimmunoassay. Both total IgE and total IgG₄ levels in patients with AIP were significantly higher than those in patients with pancreatic carcinoma (P = 0.0004 and P = 0.015, respectively). There was a significant correlation between the total IgE and total IgG₄ levels in patients with AIP and patients with atopic allergy (r(s) =0.82, P=0.0006 and r(s) =0.88, P < 0.0001, respectively). The IgE/ IgG₄ ratio in sera from patients with atopic allergy was significantly different (P = 0.0012) from this ratio in sera from patients with AIP. These results suggest that analysis of total IgE in serum might be useful in the differentiation between autoimmune pancreatitis and pancreatic carcinoma.
© 2010 The Authors. Scandinavian Journal of Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039739     DOI: 10.1111/j.1365-3083.2010.02453.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging.

Authors:  L D Dickerson; A Farooq; F Bano; J Kleeff; R Baron; M Raraty; P Ghaneh; R Sutton; P Whelan; F Campbell; P Healey; J P Neoptolemos; V S Yip
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

Review 2.  AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Authors:  D Ferastraoaru; H J Bax; C Bergmann; M Capron; M Castells; D Dombrowicz; E Fiebiger; H J Gould; K Hartmann; U Jappe; G Jordakieva; D H Josephs; F Levi-Schaffer; V Mahler; A Poli; D Rosenstreich; F Roth-Walter; M Shamji; E H Steveling-Klein; M C Turner; E Untersmayr; S N Karagiannis; E Jensen-Jarolim
Journal:  Clin Transl Allergy       Date:  2020-07-17       Impact factor: 5.871

3.  Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian women.

Authors:  J Krsteski; S Jurgec; M Pakiž; I But; U Potočnik
Journal:  Balkan J Med Genet       Date:  2017-03-08       Impact factor: 0.519

Review 4.  Immunoglobulin E-Mediated Autoimmunity.

Authors:  Marcus Maurer; Sabine Altrichter; Oliver Schmetzer; Jörg Scheffel; Martin K Church; Martin Metz
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 5.  The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease.

Authors:  Song-Chou Hsieh; Chieh-Yu Shen; Hsien-Tzung Liao; Ming-Han Chen; Cheng-Han Wu; Ko-Jen Li; Cheng-Shiun Lu; Yu-Min Kuo; Hung-Cheng Tsai; Chang-Youh Tsai; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

Review 6.  The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review.

Authors:  Ana Dugic; Cristina Verdejo Gil; Claudia Mellenthin; Miroslav Vujasinovic; J-Matthias Löhr; Steffen Mühldorfer
Journal:  Biomedicines       Date:  2022-06-26

7.  Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease.

Authors:  Emma L Culver; Ross Sadler; Adrian C Bateman; Mateusz Makuch; Tamsin Cargill; Berne Ferry; Rob Aalberse; Eleanor Barnes; Theo Rispens
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-20       Impact factor: 11.382

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.